Top 50 VC Funds & Investors in Switzerland (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Zürcher Kantonal Bank
VC Fund
|
106 | Switzerland, Japan, Germany | Seed, Series A | Health Care, Medical Device, Biotechnology | $1M–$11M |
|
Verve Ventures
VC Fund
|
103 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | $911k–$18M |
|
Foundation for Technological Innovation (FIT)
VC Fund
|
94 | Switzerland, France | Debt Financing, Grant, Seed | Health Care, Biotechnology, Information Technology | $22k–$555k |
|
SICTIC
VC Fund
|
88 | Switzerland, Germany, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $222k–$11M |
|
Wingman Ventures
VC Fund
|
54 | Switzerland, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, SaaS | $676k–$17M |
|
VI Partners
VC Fund
|
39 | Switzerland, Germany, United States | Series A, Series C, Series B | Health Care, Biotechnology, Medical Device | $3.2M–$100M |
|
3wVentures
VC Fund
|
36 | Switzerland, Spain, Austria | Seed, Angel, Series A | Software, Health Care, Information Technology | $50k–$8M |
|
Serpentine Ventures
VC Fund
|
34 | Switzerland, Germany, United States | Seed, Pre-Seed | Software, Information Technology, Automotive | $639k–$6.7M |
|
GoBeyond
VC Fund
|
34 | Switzerland, Germany, United Kingdom | Seed, Series A | Information Technology, Medical, Software | $533k–$10M |
|
Alpana Ventures
VC Fund
|
33 | United States, Switzerland, Germany | Seed, Series A, Series B | Software, FinTech, Information Technology | $822k–$45M |
|
Swisscom Ventures
VC Fund
|
30 | Switzerland, United States, France | Series B, Series A | Software, SaaS, Information Technology | $1.8M–$25M |
|
Polytech Ventures
VC Fund
|
27 | Switzerland, United States, Spain | Seed, Series A | Financial Services, FinTech, Software | $1M–$6.7M |
|
b2venture (formerly btov Partners)
VC Fund
|
24 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.1M–$30M |
|
Redalpine
VC Fund
|
24 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Biotechnology, Health Care | $800k–$59M |
|
ACE & Company
VC Fund
|
23 | United States, Switzerland, United Kingdom | Seed, Series A | Software, FinTech, Financial Services | $150k–$26M |
|
Spicehaus Partners
VC Fund
|
22 | Switzerland | Seed, Series A | Information Technology, Machine Learning, Artificial Intelligence | $889k–$9.6M |
|
High-Tech Grunderfonds
VC Fund
|
19 | Germany, Switzerland, United States | Seed, Series A | Software, Information Technology, Biotechnology | $665k–$16M |
|
BioMedPartners
VC Fund
|
19 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.4M–$69M |
|
BackBone Ventures
VC Fund
|
18 | Switzerland, Germany, Israel | Seed, Convertible Note, Series A | Information Technology, Financial Services, Robotics | $600k–$11M |
|
EquityPitcher Ventures
VC Fund
|
17 | Switzerland, Germany | Series A, Seed | Information Technology, Software, SaaS | $1.1M–$11M |
|
SIX FinTech Ventures
VC Fund
|
17 | Switzerland, United Kingdom, Spain | Seed, Series A, Pre-Seed | Financial Services, FinTech, Blockchain | $1.6M–$20M |
|
StartAngels Network
VC Fund
|
15 | Switzerland, Brazil | Seed, Series A, Series B | Medical Device, Health Care, Medical | $889k–$5.8M |
|
Session.vc
VC Fund
|
15 | Switzerland, Germany | Pre-Seed, Seed, Series A | Software, SaaS, Artificial Intelligence | $1.3M–$11M |
|
TiVentures
VC Fund
|
13 | Switzerland, Italy, United States | Seed, Series A | Software, Analytics, Renewable Energy | $555k–$3.2M |
|
Eclosion SA
VC Fund
|
12 | Switzerland | Seed, Series C | Biotechnology, Pharmaceutical, Health Care | $1.6M–$28M |
|
DAA Capital Partners
VC Fund
|
12 | Switzerland | Seed, Series A | Information Technology, Software, Film | $778k–$7.2M |
|
TR Invest
VC Fund
|
12 | Switzerland, Spain, Sweden | Seed, Series A | Manufacturing, Software, Apps | $350k–$3.3M |
|
M Ventures
VC Fund
|
12 | United States, Switzerland, United Kingdom | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.1M–$67M |
|
Technology Fund
VC Fund
|
12 | Switzerland | Debt Financing, Grant | Information Technology, Software, Energy | $1.3M–$5.6M |
|
FYRFLY Venture Partners
VC Fund
|
11 | United States, Switzerland, France | Seed, Series A | Software, SaaS, Artificial Intelligence | $1.3M–$14M |
|
Privilege Ventures
VC Fund
|
11 | Switzerland, France | Seed, Series A | Health Care, Hardware, Software | $1.1M–$5.3M |
|
CV VC
VC Fund
|
10 | United States, Switzerland, Germany | Seed, Pre-Seed | Blockchain, Software, Information Technology | $125k–$6M |
|
Helvetia Venture Fund
VC Fund
|
10 | Germany, Switzerland, Spain | Seed, Series A | Financial Services, Information Technology, FinTech | $3.3M–$11M |
|
Gentian Investments
VC Fund
|
10 | Switzerland, Germany, United States | Seed, Series A | Software, Artificial Intelligence, Information Technology | $889k–$13M |
|
Lakestar
VC Fund
|
10 | United States, Germany, United Kingdom | Series A, Seed, Series B | Software, FinTech, Information Technology | $2M–$91M |
|
Sofinnova Partners
VC Fund
|
10 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.4M–$57M |
|
4FO Ventures
VC Fund
|
10 | Switzerland | Series A, Seed, Series B | Artificial Intelligence, Health Care, Medical | |
|
Swiss Founders Fund
VC Fund
|
10 | Switzerland, Singapore, Germany | Seed, Pre-Seed, Series A | E-Commerce, Internet, Information Technology | $210k–$5M |
|
Schroder Adveq
VC Fund
|
10 | Switzerland, United States, India | Series B, Series C, Series A | Biotechnology, Health Care, Therapeutics | $5.6M–$100M |
|
TX Ventures
VC Fund
|
10 | Switzerland, Finland, Germany | Seed, Series A, Series B | Financial Services, FinTech, Finance | $1.3M–$7.8M |
|
FortyOne Group
VC Fund
|
9 | Switzerland, Germany | Seed, Series A | Information Technology, Software, Information Services | $667k–$9.1M |
|
EQT life science
VC Fund
|
9 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.4M–$70M |
|
Momenta
VC Fund
|
9 | United States, Switzerland, Canada | Seed, Series A, Series B | Software, Internet of Things, Artificial Intelligence | $150k–$21M |
|
PostFinance
VC Fund
|
9 | Switzerland, United Kingdom, Germany | Seed, Series A, Series B | Financial Services, FinTech, Insurance | $444k–$18M |
|
Innosuisse
VC Fund
|
9 | Switzerland, United States, Taiwan | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Medical Device | $6k–$1.4M |
|
Tomahawk.VC
VC Fund
|
9 | Switzerland, Germany, United States | Pre-Seed, Seed, Series A | FinTech, Cryptocurrency, SaaS | $860k–$49M |
|
Hammer Team
VC Fund
|
9 | Switzerland, United States | Seed, Series A, Series B | Software, Information Technology, SaaS | $2.2M–$7.2M |
|
Swisscom
VC Fund
|
8 | Switzerland, United States, Canada | Seed, Grant | Software, Artificial Intelligence, Analytics | $555k–$3M |
|
Atlantic Labs
VC Fund
|
8 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Health Care, Software, Information Technology | $850k–$27M |
|
Acequia Capital (AceCap)
VC Fund
|
8 | United States, United Kingdom, France | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $500k–$19M |
| Access all 1976 VC funds in Switzerland startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Switzerland, Japan, Germany
Investor stats
- Total investments: 136
- Round size: Seed $1M–$3.9M; Series A $2M–$11M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Helio — Carbon Aware Cloud Computing.
- Tune Insight — Tune Insight orchestrates secure collaborations on sensitive data between multiple organizations to extract collective insights.
- Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 200
- Round size: Seed $911k–$5M; Series A $2.1M–$12M; Series B $4.1M–$18M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
The Foundation for Technological Innovation (FIT) has been helping startups since 1994, encourages entrepreneurship & supports innovation.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Debt Financing, Grant, Seed
- Geography: Switzerland, France
Investor stats
- Total investments: 117
- Round size: Seed $111k–$111k; Grant $22k–$111k; Debt Financing $111k–$555k
- Lead/follow: 95% lead, 5% follow
Portfolio highlights
- Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
- PeriVision — Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
- AdVentura Works — AdVentura Works is a Swiss technology company offering material handing as a service to logistics and industrial companies
How to Invest in Swiss Startups That Last The Investor community of the Swiss ICT Investor Club (SICTIC) helped to fund to more than 160 Swiss tech startups to date. While doing so, they learned a lot about what to watch out for and how to foster success. Read more Get your FREE angel handbook
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 100
- Round size: Seed $555k–$2.2M; Pre-Seed $222k–$980k; Series A $2.8M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Axom — Axom automating visual inspection through image analysis in the healthcare industry.
- Gaia Tech — Gaia Technologies turns agricultural sidestreams into high-value ingredients for cosmetics, food, and feed manufacturers.
- PeriVision — Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
We dedicate our know-how, experience and energy to the new generation of startup founders, helping them navigate the skies on their way to success.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, United Kingdom
Investor stats
- Total investments: 58
- Round size: Seed $1.2M–$5.7M; Pre-Seed $676k–$2.3M; Series A $3.3M–$17M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $83M in 2020
Portfolio highlights
- Ascento — Secure, maintain, and inspect outdoor assets by reducing the intervention times and augmenting data capturing capability.
- Tune Insight — Tune Insight orchestrates secure collaborations on sensitive data between multiple organizations to extract collective insights.
- Saeki Robotics — Building the future of autonomous robotic manufacturing.
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 96
- Round size: Series A $3.3M–$24M; Series B $3.2M–$36M; Series C $7M–$100M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $119M in 2020
Portfolio highlights
- Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
- Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Angel, Series A
- Geography: Switzerland, Spain, Austria
Investor stats
- Total investments: 42
- Round size: Seed $50k–$2.7M; Angel $555k–$2M; Series A $1.1M–$8M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 1999
Portfolio highlights
- Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
- GUURU — Convert undecided shoppers into confident buyers with instant, authentic advice from your expert community.
- Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Serpentine Ventures (SERV) is the investment arm of the Swiss startup group. Serpentine refers to the meandering roads found across the Swiss Mountains. Unreachable mountain peaks become accessible by following the serpentine path.
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 69
- Round size: Seed $1.1M–$6.7M; Pre-Seed $639k–$1.7M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- DuraMon — DuraMon provides sensor for monitoring durability in concrete.
- Arda Biomaterials — Arda Biomaterials transforms waste feedstocks into smarter, circular biomaterials for fashion, home goods, automotive and more.
- Antefil Composite Tech — Microengineered hybrid fibres for lightweight structures. What are hybrid fibres? The fastest, most affordable, scalable, and high-quality solution for the production of energy-efficient lightweight structures. Hybrid fibres are glass reinforcement fibres which are individually coated with a meltable, recyclable plastic.They provide all the material needed to produce lightweight composites in a perfect mix - at
GoBeyond is a FinTech company transforming angel investing into a new scalable asset class for small and large, novice to experienced investors. It offers a unique deal platform, portfolio tools, syndication/pooling, due diligence, investment monitoring services, training and certified deal leaders.Its clients are individuals, familyoffices, professional groups and corporations. It is active in the EU, Switzerland and the US. GoBeyond also offers educational training modules for angel investors in 11 categories.
Show more...Investment focus
- Industry: Information Technology, Medical, Software
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 161
- Round size: Seed $533k–$5M; Series A $1.1M–$10M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- LEND — LEND provides peer to peer lending in Switzerland. It connects investors with borrowers. Moreover, investors earn substantial returns and borrowers benefit from low interest rates. The company is based in Switzerland and it was founded in 2015.
- AVAtronics — AVA Active Noise Cancellation (ANC) Solution is a breakthrough in Audio Industry. AVA is the first and only TRUE WIDE-BAND ANC in the market capable of selectively cancelling all annoying noises we want to get rid of without compromising the quality of Music or speech.
- Blumer — Blumer is a social networking platform that provides social networks that can monetize time by consuming advertisements, selling nfts, and making crypto transactions. It offers social networks, crypto, digital marketing, and blockchain.
Alpana Ventures is a Swiss VC focusing on digital transformation.Since 2016 we backed 45 founder teams with 3 Funds, supporting them in their journey towards a positive impact.Committed to value creation, we discover deep tech solutions in Switzerland, Europe and the US.We invest to embed them into innovative business models and back them tobecome global market leaders.Applying ESG criteria, our portfolio companies help create a more sustainable future.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, Germany
Investor stats
- Total investments: 95
- Round size: Seed $822k–$3.5M; Series A $2.2M–$8M; Series B $3M–$45M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
- Nezasa — Nezasa’s travel booking solution empowers travel brands globally to combine all planning and booking related actions into one seamless end-to-end experience.Our tools, enable to plan and book any type of multi-product or multi-stop itinerary.TripBuilder Hyper-personalised packaging Real-time planning and booking of personalised itinerariesPowerful, easy to use and very interactive Deep integration possibilities into existing fulfilment landscapes Enterprise-grade, proven with large TO customersTripBooster Hyper-personalised In-Destination Upselling The extension of TripBuilder’s power throughout the entire travel lifecycle The perfect travel companion Seamless purchasing of perfectly fitting additional products Smart upselling recommendation, available in both a push and pull mode
- Tinamu — Tinamu Labs has developed a technology that converts commercially available drones into camera equipment reaching professional standards.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Swisscom Ventures is an venture capital arm of Swisscom AG, that specializes in early stage tech investments founded in 2007.Swisscom Ventures invests in growth companies with emerging business models and technologies of strategic relevance to Swisscom's core business. As a value-add investor, Swisscom brings its investees the technicalexpertise and strategic insights of an incumbent telecom operator. We act as a bridge to Swisscom's operational business units, which portfolio companies can also leverage as a test environment for their products and services.Swisscom Ventures seeks minority stakes in companies related to the information/communications/entertainment space.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series B, Series A
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 122
- Round size: Series A $1.8M–$16M; Series B $2M–$25M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- viboo — viboo offers self-learning predictive control on the basis of physics-informed Machine Learning as a cloud service to smart-thermostat and building automation companies.
- ecoRobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
- AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Polytech Ventures are an early stage VC firm based in Switzerland with a strong international focus. Their strategic location at EPFL in Lausanne grants us access to one of the most dynamic and recognized innovation centers in the world
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: Switzerland, United States, Spain
Investor stats
- Total investments: 46
- Round size: Seed $1M–$3.5M; Series A $1.1M–$6.7M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- yamo — Frische Bio-Kindernahrung von yamo, so lecker wie selbstgemacht und kostenlos direkt zu dir nach Hause geliefert. Jetzt probieren und profitieren.
- Relai — Relai is a Bitcoin investment app that allows anyone to buy bitcoin within one minutes or set up an automated savings plan.
- Earny — Payroll management built for Startups & SMEs. Swiss payroll service with no hidden fees & no hassle
Btov Partners is a venture capital firm focused on early-stage investments in digital and industrial technology companies. With investment teams in Digital and Industrial Tech, Btov invests EUR 50m per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 190
- Round size: Seed $1.1M–$5.6M; Series A $3.8M–$14M; Series B $4M–$30M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
- Calvin Risk — We help companies manage the risks of their AI algorithms!
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Redalpine is one of the leading European Venture Capital investors with a focus on highly scalable start-ups. The firm's mission is to help talented entrepreneurs turn an ambitious vision into reality by providing money, experience, coaching, and a strong network. The firm is focused on seed and early-stage investments in disruptivetechnologies in tech and health tech. Redalpine launched its first fund (Redalpine Capital I) in 2007, following the founding partners’ track record of some excellent trade sales and IPOs as serial entrepreneurs and professional angel investors. In 2021 Redalpine closed its sixth fund (Redalpine Capital VI) and currently has approx. USD 1 Billion in AUM. The highly interdisciplinary Redalpine team supports more than 70 portfolio companies with operational and sector-specific expertise and with a rich international network.Redalpine started with its first fund (Redalpine Capital I) in 2007 based on the track-record of some excellent trade-sales and IPOs as serial entrepreneurs and professional angel investors. Redalpine sucessfully launched Redalpine Capital II in 2012 and Redalpine Capital III in 2016. The funds are registered in Luxemburg and backed by dozens of experienced entrepreneurs and investors representing various countries, and a broad range of industries.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 130
- Round size: Seed $800k–$6.7M; Series A $2M–$24M; Series B $12M–$59M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Zealy — A simple, fun & creative way to join trendy communities, make an impact and earn rewards.
- Genialis — Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkersand optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.
- Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
ACE & Company (“ACE”), founded in 2005, is a global investment group specialized in private investments with total assets of over $1.6 bn across three investment strategies and investment solutions. With headquarters in Geneva and offices in London, New York, and Cairo, ACE’s global presence brings the company in direct contact with sourcingpartners, investment firms, as well as entrepreneurs and provides investors unparalleled access to a network of opportunities. ACE’s passion is for finding investment opportunities where we have an advantage through many years of relationship building, a carefully developed position of knowledge in the sectors which we are active, and a culture of efficiency to gain first mover’s advantage. ACE’s purpose is to offer investors a long-term and collaborative investment approach that values honesty, transparency and rigorous execution, so that our strategies not only provide unique access to value accretive, risk-managed deals, but fosters what we consider our bedrock—trust.ACE’s progress has been marked by a globally respected track record since the Company was founded in 2005. In the last four years we have increased our total assets by fivefold and in 2017 received the Swiss Financial Supervisory Authority (FINMA) authorization.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $150k–$5.8M; Series A $3M–$26M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- DePoly — DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. Weexpect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
- ANYbotics — ANYbotics provides autonomous legged robots for industrial applications to provide high availability and reliability in automated routine inspections.
- Pledge — Pledge makes it simple for businesses of every size to measure, reduce and offset the climate impact of their products.
We are a Swiss venture capital investor, investing in early-stage tech start-ups from Switzerland. Are you looking for private equity? Join our network now.
Show more...Investment focus
- Industry: Information Technology, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 27
- Round size: Seed $889k–$1.7M; Series A $3.3M–$9.6M
- Lead/follow: 74% lead, 26% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Axom — Axom automating visual inspection through image analysis in the healthcare industry.
- AICA SA — AICA believes programming robots should be at everyone's reach. We combine Artificial Intelligence & an intuitive interface, to help you relocate your production.
- Klepsydra — Klepsydra Technologies is an embedded software in order to build advanced autonomous applications in a more efficient and reliable manner.
High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 373
- Round size: Seed $665k–$5.1M; Series A $1.5M–$16M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
- Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 80
- Round size: Series A $5.4M–$20M; Series B $4.4M–$69M; Series C $5.2M–$21M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Tricares — TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Information Technology, Financial Services, Robotics
- Stage:Seed, Convertible Note, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 35
- Round size: Seed $819k–$4M; Series A $5M–$11M; Convertible Note $600k–$8M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Aepsy — Finde Psychologinnen oder Psychologen, die zu dir und deinem Anliegen passen. Freite Termine und kostenlose Intros jederzeit online.
- Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
- Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.
EquityPitcher is an Early-Growth Venture Capital firm that supports promising startups from the DACH region. Through close cooperation with renowned industry experts, investors and exit partners, we pave the way for entrepreneurs to attain the three decisive success factors: know-how, contacts and capital.
Show more...Investment focus
- Industry: Information Technology, Software, SaaS
- Stage:Series A, Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 31
- Round size: Seed $1.1M–$5.5M; Series A $3M–$11M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- vestr — Vestr facilitates the creation and life-cycle management of actively managed investment products and offers a software-as-a-service to its clients. The software engine handles everything from portfolio rebalancing to investor reporting and audit trails, so issuers and portfolio managers can focus on their core competencies. vestr is a pure playtechnology company and does not issue their own structured products.
- Wingtra — WingtraOne is an easy-to-use drone that delivers consistent, high-quality survey data faster and at a lower cost than other surveying tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SIX invests in global early stage start-ups, focusing on companies that provide value to the Swiss financial center.
Show more...Investment focus
- Industry: Financial Services, FinTech, Blockchain
- Stage:Seed, Series A, Pre-Seed
- Geography: Switzerland, United Kingdom, Spain
Investor stats
- Total investments: 31
- Round size: Seed $1.6M–$7.6M; Series A $3.9M–$20M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $56M in 2018
Portfolio highlights
- Relio — This is a default page description
- Keyrock — We provide innovative algorithmic trading and market making solutions for digital assets to thrive. Our unique approach to liquidity allows our partners to expand and help create a new tokenized economy.
- TAINA Technology — Fully automated validation & compliance of FATCA and CRS Tax Forms in all formats including scanned hard copies, online and mobile
StartAngels Network is a Zurich-based angel investment firm that provides investment consulting services.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Brazil
Investor stats
- Total investments: 24
- Round size: Seed $889k–$2.3M; Series A $2M–$3.6M; Series B $1.7M–$5.8M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Medyria — Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland.
- Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
- Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
At session we back early-stage companies in the Software and Consumer space. As active investors, we can only partner with a few companies. When we do, we roll up our sleeves and get to work, providing entrepreneurs with access to expertise and insights across the entire spectrum of company building.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany
Investor stats
- Total investments: 17
- Round size: Seed $1.3M–$2.2M; Series A $3.4M–$11M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Jua — A new paradigm in weather forecasting. AI learning physics. Delivering accuracy beyond expectation. Covering use cases beyond belief. Accessible to everyone, wherever in the world they are. The world's first end to end deep learning model for weather forecasting, delivered on an intuitive platform for anyone to customise it. Startups,governments and large companies alike can now develop global, high frequency and high accuracy weather models within days.
- Saporo — Improve cyber resistance by prioritizing and reducing user access risk.
- deskbird — Most intuitive and people-centric - deskbird's hybrid workplace solution that employees will love. For all flexibe companies, from startup to corporate.
TiVenture is a seed investment fund owned by the Fondazione Centenario Banca Stato that invests in early stage companies with innovative technologies and high growth potential, principally in southern Switzerland. TiVenture is actively looking and ready to support exceptional founders and entrepreneurs developing scalable products for the globalmarket. TiVenture has a diversified portfolio of companies and is mainly active in the life science, medical, high-tech and IT sectors.
Show more...Investment focus
- Industry: Software, Analytics, Renewable Energy
- Stage:Seed, Series A
- Geography: Switzerland, Italy, United States
Investor stats
- Total investments: 15
- Round size: Seed $555k–$2.1M; Series A $1.9M–$3.2M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- BigOmics — Get robust and reproducible results in a few clicks with Omics Playground: your user-friendly Omics Data Analysis Software.
- Hive Power — Hive Power provides a SaaS platform to optimise your existing electrical distribution grid, both from the technical and economic points of view.
- Gaia Turbine — Gaia Turbine creates a plug-and-play hydroelectric microturbine with an efficiency of over 90% that is perfect for aqueducts and the smallest necessary outflows. Gaia's two patent applications have been filed to protect the technology of the mini/micro hydroelectric turbine.
Eclosion assists entrepreneurs with the necessary resources to bridge the gap between their laboratories and the stage where the start-up
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series C
- Geography: Switzerland
Investor stats
- Total investments: 16
- Round size: Seed $1.6M–$2.7M; Series C $20M–$28M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- KYLYS — KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
- Genkyotex — Genkyotex is dedicated to the development of innovative drugs which block enzymes that produce oxygen radicals. Such novel drugs will allow the treatment of oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy, giving them a significant competitive advantage.Genkyotex targets its technology initially to the therapeutic areas of cardiovascular, metabolic and neurodegenerative diseases.
- MPC Therapeutics — MPC Therapeutics develops a novel class of compounds with application in Immunotherapy and Metabolic diseases
DAA Capital Partners is a Swiss-based private equity firm founded with the ambition to make a difference. We believe in creating value through long-term partnerships with talented entrepreneurs, managers and investors, and supporting them by leveraging our multidisciplinary expertise and our global network
Show more...Investment focus
- Industry: Information Technology, Software, Film
- Stage:Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 13
- Round size: Seed $778k–$1.8M; Series A $4.1M–$7.2M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Wyth — Wyth makes technologies that help humans create meaningful relationships by bringing emotions, stories and connections beyond the interface.
- Smeetz — Smeetz is the future of a unified, data-driven and dynamic pricing-oriented commerce for attractions and cultural venues.
- Tinamu — Tinamu Labs has developed a technology that converts commercially available drones into camera equipment reaching professional standards.
Private Investment Company
Show more...Investment focus
- Industry: Manufacturing, Software, Apps
- Stage:Seed, Series A
- Geography: Switzerland, Spain, Sweden
Investor stats
- Total investments: 26
- Round size: Seed $350k–$3.2M; Series A $2.1M–$3.3M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- CompPair — CompPair is an EPFL spin-off solving damage issues for the composite materials industry by developping smart sustainable textiles.
- Pipra — PIPRA AG (Pre-Interventional Preventive Risk assessment) is developing a cutting-edge AI-based pre-operative test to assess a patient's risk of suffering from cognitive disorders after surgery.
- Fidentity — Fidentity wants to inject trust from the real world into online interactions.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 119
- Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
- BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Climate protection through innovative technologies. The Technology Fund offers loan guarantees to Swiss companies whose novel products contribute to a sustainable reduction in greenhouse gas emissions
Show more...Investment focus
- Industry: Information Technology, Software, Energy
- Stage:Debt Financing, Grant
- Geography: Switzerland
Investor stats
- Total investments: 20
- Round size: Debt Financing $1.3M–$5.6M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- FGen — FGen is a Swiss start-up company founded 2011 in Basel as a spin-off from the Department of Biosystems Science and Engineering of the ETH Zurich. As a contract reasearch organization we collaborate with partners from Biotech, Life Sciences, and Pharma in order to establish efficient bioprocesses and to develop new biopharmaceuticals.
- Calopad — Calopad, awarded by the Swiss Confederation, offers a unique and the most holistic solution in pain therapy and muscle regeneration. The therapeutic deep heat of 42 degrees solves any muscle pain, muscle tension, or muscle spasms of chronic patients in the long term and in a highly efficient way through new forms of therapy. With the associatedapp, Calopad brings the physiotherapist digitally into any user's home and enables personalized all-around care in real time - utterly independent of time and place. In the future, the modular design will make it possible to combine different therapies such as heat, cold, or light with just one device, opening up the possibility of new therapeutic successes.
- Selfrag — SELFRAG AG is specialized in the development of high voltage pulse power products, plants and systems for selective fragmentation of solid materials.
Fyrfly Venture Partners is a venture capital firm that focuses on data and intelligence. The firm prefers to invest in startups and early-stage companies in the information technology sector.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A
- Geography: United States, Switzerland, France
Investor stats
- Total investments: 34
- Round size: Seed $1.3M–$6.4M; Series A $3.4M–$14M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Nova — Automate & scale your customer acquisition with AI. Take your personalized marketing to the next level with Nova. Request a demo and discover how our platform can transform your business.
- Portal AI — Unlock Brand Value with Intelligent Marketing.
- Amplo — Amplo is a no code platform that allows industrial customers to automate their machine operations using accessible AI.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Privilege Ventures is the venture capital arm of Privilège Management and invest in seed and early stage companies. Geographical focus is Switzerland and the rest of Europe. Focus sectors are industrial-tech, med-tech, wearables and in general ICT.
Show more...Investment focus
- Industry: Health Care, Hardware, Software
- Stage:Seed, Series A
- Geography: Switzerland, France
Investor stats
- Total investments: 12
- Round size: Seed $1.1M–$4.7M; Series A $4.1M–$5.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Wyth — Wyth makes technologies that help humans create meaningful relationships by bringing emotions, stories and connections beyond the interface.
- Smeetz — Smeetz is the future of a unified, data-driven and dynamic pricing-oriented commerce for attractions and cultural venues.
- Avelo — Our mission is to save lives by bringing fast and actionable infectious disease diagnosis closer to the patient. Avelo's solution is a breath collection device. It works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia
We invest in blockchain
Show more...Investment focus
- Industry: Blockchain, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: United States, Switzerland, Germany
Investor stats
- Total investments: 46
- Round size: Seed $139k–$6M; Pre-Seed $125k–$140k
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Pyrpose — Pyrpose is a climate finance platform.
- Sytemap — We are building a blockchain-based property record to help home buyers and financial companies access, view and verify properties starting from digitizing Estate project layouts (Sytemap) Sytemap is a first step that allows us access to a large pool of property data. The end goal can really be described as building Zillow for Africa.
- Natix Network — Earn passive income by owning a part of your favourite city
Helvetia has a long tradition: in over 150 years, it has grown from a number of Swiss and foreign insurance companies into a successful international insurance group. Today, Helvetia has subsidiaries in its home market Switzerland as well as in the countries that make up the Europe market area: Germany, Italy, Austria and Spain. Helvetia is alsopresent in France with its Specialty Markets market area and through selected regions worldwide.
Show more...Investment focus
- Industry: Financial Services, Information Technology, FinTech
- Stage:Seed, Series A
- Geography: Germany, Switzerland, Spain
Investor stats
- Total investments: 28
- Round size: Seed $3.3M–$3.9M; Series A $5.4M–$11M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- INKI.TECH — Equip your business with high-end, secure IT equipment through INKI's device-as-a-service model. Reduce operational costs, increase agility, and embrace sustainability while minimizing total cost of ownership.
- CamperBoys — CamperBoys rents out fully equipped camper vans in Munich, Hamburg, Stuttgart, Düsseldorf, Leipzig-Halle & Berlin.
- Urban Connect — Urban Connect is a corporate mobility platform offering company employees access to a fleet of low-carbon, shared vehicles like e-bikes, bikes, e-scooters and e-cars. The offering is structured as a mobility-as-a-service (MaaS) solution. The company services large blue chip clients like Roche, Avaloq, Hilti, Sonova or Zurich Insurance. The team iscomposed of a number of people from different nationalities & backgrounds, all with the common goal of helping companies reduce their carbon and space footprints.
Gentian is an early-stage investment company founded by the Entrepreneurs Elian Kool and Gerhard Gerner. We focus on investments in SaaS platforms, Mobile, Robotics/Drones and adjacent areas we have a passion for.Based in Switzerland, most of our investments are in the DACH region, but with a clear focus on a global market.We investexclusively in enthusiastic teams, which we support with our experience as entrepreneurs as board member or advisor.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 13
- Round size: Seed $889k–$10M; Series A $2.1M–$13M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Wyth — Wyth makes technologies that help humans create meaningful relationships by bringing emotions, stories and connections beyond the interface.
- Aleno — aleno is the most professional online reservations system for restaurants. Full access to all data. Your own branding and design.
- aspaara AG — Algorithmic solutions for intelligent planning. Improve profitability and enhance strategic decision-making by gaining actionable business insights in real-time.
Lakestar is a venture capital firm investing in technology companies led by exceptional entrepreneurs. Early investments included Skype, Spotify, Facebook, and Airbnb. Since raising the first fund in 2013, Lakestar manages an aggregated volume of over EUR 1bn across three early-stage funds, and more recently a growth fund. The company has expandedand broadened its portfolio and holds investments in the likes of Opendoor, Oscar, GetYourGuide, Glovo, Sender, Eigen, Five, Revolut, and Hometogo to name a few. Lakestar has a presence in Berlin, Zurich, and London.Lakestar helps companies to identify new markets and expand into them rapidly, with a focus on the US and Europe. The team advises and supports portfolio companies in business development, recruitment, technology, and marketing. The investments range from early-stage companies to those in their growth stage.
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 151
- Round size: Seed $2M–$10M; Series A $3.5M–$33M; Series B $16M–$91M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Mindgard — Mindgard rapidly uncovers cyber threats against Artificial Intelligence. Our product empowers businesses to securely deploy their mission-critical AI within an everchanging cyber landscape.
- Neko Health — Neko Health is a Swedish health-tech business. Its ambition is to build a healthcare system that can help people stay healthy by focusing on prevention and early detection. Neko has created a new medical scanning technology concept that allows for comprehensive and non-invasive health data collection that is both convenient and economical for thegeneral people.
- Dexory — Robotics, AI, automation, digital twin technology, data-led, inventory checks
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 232
- Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
4FO Ventures
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Switzerland
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- ecoRobotix — ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs.
- ARTIRIA Medical — Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to revolutionize the limits of neurointerventional procedures, enabling a seamless navigation and stroke treatment.
- Giotto.ai — We complement modern machine learning with topology, the science of shapes. Increased interpretability and robustness are the direct benefits of this novel approach.Our first product, Giotto Compliance (compliance.giotto.ai), facilitates the consolidation of clinical evidence in the context of regulatory processes by leveraging proprietary NLPtechnology. This state-of-the-art AI software allows significant time and cost savings for medical device companies and medical writers.
Swiss Founders Fund is a seed and early stage investment fund based in St.Gallen, Switzerland. SFF invests in and builds companies globally.
Show more...Investment focus
- Industry: E-Commerce, Internet, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, Singapore, Germany
Investor stats
- Total investments: 34
- Round size: Seed $800k–$3.5M; Pre-Seed $210k–$860k; Series A $2.1M–$5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Hybr1d — Hybr1d is an end-to-end workforce management system. Manage everything from onboarding, procurement, devices, and attendance to offboarding from a single platform.
- Orderli — Orderli is the platform for restaurants, we help you sell more and efficiently through our QR based ordering solution.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
Schroders Capital provides investors with access to a broad range of private asset investment opportunities, portfolio building blocks and customised private asset strategies. With over $65 billion assets under management, we offer a diversified range of investment strategies, including real estate, private equity, secondaries, venture capital, infrastructure, securitised products and asset-based finance, insurance-linked securities and impact investing.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Series A
- Geography: Switzerland, United States, India
Investor stats
- Total investments: 33
- Round size: Series A $5.6M–$14M; Series B $8.6M–$100M; Series C $30M–$100M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Lenskart — Lenskart, the first of its kind online optical store in India, has made it possible to acquire a good quality pair of specs with prescription lenses for just Rs. 399, all this while you sit in the comfort of your home. With a 48-hour free home delivery guarantee and 365 days return policy, Lenskart.com is doing what e-commerce hasn’t been able todo in India yet.The website has over 500 designs of eye frames, in multiple colors, for all age groups, from Rs. 399 all the way to Rs. 4,000 for a pair. All one needs to do is select a frame, fill in their power, and place an order. You can pay online or at the time of delivery.Lenskart.com has the biggest collection of discounted contact lenses consisting of all top-notch brands (viz. Johnson & Johnson, Bausch & Lomb, Ciba Vision are to name a few) and be it disposable, toric, colored or bifocal contact lenses, you can find all possible types here. Lenskart is dedicated to providing its customers with a simple, hassle-free way to replace their contact lenses. One can receive the exact same contact lens, their doctor prescribed, delivered to their door, at a great price.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
We help smart startups to establish and enhance their products and services. We also assist our holdings with their strategic planning activities and offer them shared services and networking platforms. Our collaboration with these entrepreneurs is focused on the pursuit of long-term goals.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Seed, Series A, Series B
- Geography: Switzerland, Finland, Germany
Investor stats
- Total investments: 17
- Round size: Seed $1.3M–$5.5M; Series A $2.2M–$7.8M
- Lead/follow: 76% lead, 24% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Relio — This is a default page description
- Tidely — Liquidity management the easy way!The liquidity platform Tidely helps to actively manage the financial success of your company - whether for start- ups, SMEs or entrepreneurs. With easy-to-use, intelligent tools, Tidely creates transparency about the financial situation and supports the optimization of cash flow. The entrepreneur thus not onlyunderstands the financial situation at a glance, but can also use the insights as a basis for decision-making when faced with liquidity-related challenges.Tidely was developed with and for entrepreneurs and therefore knows exactly which features are important for effective liquidity management: Tracking the development of cash balances in real time, seeing today how much money the company will have available tomorrow, in a week or a year thanks to intelligent cash flow forecasts, and testing the impact of entrepreneurial decisions on liquidity with the help of scenario analyses - all this and more is possible with Tidely‘s tools.Without setup effort, without outdated data, without error-prone Excel models.
- Selma Finance — Selma is your digital financial assistant from Switzerland. Get your individual investment plan and start taking care of your financial future with Selma. Start for free!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!At Fortyone AG they hold participations in non-listed companies. They are guided by the question: "Can they make a difference?". As active investors, they make investments in which, in addition to the financial resources, they can add value to their knowledge, their experience and their relationships. In order to live up to this smartmoney approach and to be able to actively influence the corporate design, they usually require the involvement of the Board of Directors. The scope of the participation depends on the requirements.
Show more...Investment focus
- Industry: Information Technology, Software, Information Services
- Stage:Seed, Series A
- Geography: Switzerland, Germany
Investor stats
- Total investments: 13
- Round size: Seed $667k–$9.1M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Gossik — Gossik is the productivity assistant that helps you to stay on top of your tasks and responsibilities so that you can reach your full potential and crush your goals.
- matriq — matriq offers innovative solutions for the part-individual marking of plastic components of all kinds. With the DynamicMold technology, marking takes place directly in the manufacturing machine, whether in injection molding, blow molding or thermoforming. Besides the application for traceability, the DynamicMold technology also offers thepossibility to integrate product protection.
- milKit — Create your website with blocks Add block patterns Block patterns are pre-designed groups of blocks. To add one, select the Add Block button in the
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 132
- Round size: Series A $6.4M–$50M; Series B $5.4M–$69M; Series C $10M–$70M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $279M in 2023
Portfolio highlights
- VarmX — VarmX is a pharmaceutical spin-off from the Leiden University Medical Center. The mission of VarmX is to develop and manufacture therapeutic proteins to instantaneously restore blood clotting in bleeding patients. The lead product in the pipeline of VarmX is PseudoXa. PseudoXa is a modified recombinant human coagulation factor X which is capable ofimmediately restoring blood clotting in the presence of direct factor Xa anticoagulants (DOACS) such as rivaroxaban, apixaban, and edoxaban.These factor Xa coagulants are taken by millions of patients world-wide for the prevention and treatment of thrombosis and stroke, but as a side effect severe bleeding often occurs. PseudoXa is capable of stopping and preventing such bleedings thus making the usage of DOACS much safer.
- Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
Momenta is the leading Digital Industry venture capital + growth firm. We accelerate entrepreneurs and leaders devoted to the digitization of energy, manufacturing, smart spaces, and supply chains. Since 2012, our team of deep industry operators have made over 100 investments in entrepreneurs and helped scale over 150 industry leaders via ouraward-winning executive search and strategic advisory practices.
Show more...Investment focus
- Industry: Software, Internet of Things, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 66
- Round size: Seed $150k–$5.4M; Series A $2.5M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Pulse Industrial — Pulse Industrial is using IoT to reduce steam loss in industrial plants by remote monitoring of steam traps in real-time to detect failures.
- Tvarit — Reduce Rejections in Casting with easy to use, secure & fast to implement industrial AI.
- APERIO — APERIO validates operational data at scale to improve data accuracy, security, and value, allowing for smarter decisions based on real-time, superior data.
It is the fifth largest retail financial institution in Switzerland.
Show more...Investment focus
- Industry: Financial Services, FinTech, Insurance
- Stage:Seed, Series A, Series B
- Geography: Switzerland, United Kingdom, Germany
Investor stats
- Total investments: 18
- Round size: Seed $444k–$6.7M; Series A $2.4M–$18M; Series B $6.1M–$9.3M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Token.io — The broadest coverage for open banking in Europe. Accept A2A payments. Add open payments to your platform. Access user permissioned financial data data.
- Properti — "building the world's greatest real estate company"Properti is a modern, young and pioneering PropTech startup founded in November 2019. Through our unique Properti System, which combines the latest technologies, in-depth expertise and world-class marketing, we provide an exclusive service. Our mission is to change the real estateindustry sustainably with the symbiosis of technology and people to build trustworthiness and transparency. Our goal is to offer customers a full service around the housing ecosystem.
- Credit Exchange — Credit Exchange is a financial firm that provides mortgage exchange, credit management, lending, banking, and financial consulting services.
Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Pre-Seed, Seed
- Geography: Switzerland, United States, Taiwan
Investor stats
- Total investments: 72
- Round size: Seed $500k–$1.4M; Grant $19k–$1.1M; Pre-Seed $6k–$1.4M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Pelt8 — Pelt8 enables climate action through the platform with scalable processes and controls to collect sustainability-related data in an easy and traceable way.
- Atinary — Atinary is an end-to-end AI, machine learning, robotics, and cloud computing technology platform for digitizing R&D operations.
- Ascento — Secure, maintain, and inspect outdoor assets by reducing the intervention times and augmenting data capturing capability.
Tomahawk.VC (www.tomahawk.vc) is an entrepreneur-led early-stage venture capital firm founded by serial entrepreneur Cédric Waldburger. We invest in global-first companies in Pre-Seed, Seed and Series A rounds. We give honest and quick feedback and value empathy, execution and clarity. We think that data beats experience beats opinion.Global-first companies are ventures that think and act global from the very start. They hire the best talent from anywhere in the world and build company culture incorporating remote employees from day 1. Investments range from USD 100k-1M per transaction and up to USD 2M per company. Global focus, based in Switzerland. Get in touch via www.Tomahawk.VC.
Show more...Investment focus
- Industry: FinTech, Cryptocurrency, SaaS
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 24
- Round size: Seed $2.6M–$49M; Pre-Seed $860k–$2.5M; Series A $3.9M–$6M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Buynomics — buynomics is the leading solution to optimize your product portfolio. Our clients use buynomics to optimize pricing, promotions, & portfolio architecture.
- Pods — Building DeFi. Strategies, primitives and tooling. Welcome to Pods.
- Daylight — Our transaction recommendation API helps apps, protocols, and creators grow transactions and revenue.
The “Hammer Team” is the investment vehicle of Ariel Luedi. The mission is to support software companies during their startup and growth phase. Hammer Team provides its companies with venture capital but also with expertise in different areas required to grow a company (Sales Ops, Product Management, Customer Success, Finance, Marketing, Legal, Taxor Branding). Ariel and his team have created a platform for those companies to communicate openly, leverage synergies and find new ways of solving challenges.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Series B
- Geography: Switzerland, United States
Investor stats
- Total investments: 12
- Round size: Seed $2.2M–$5.5M; Series A $5M–$7.2M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Zoovu — Zoovu is the next generation digital commerce search platform that merges context and meaning across channels to help brands and retailers have rich, personalized conversations with their customers. Zoovu’s proprietary AI naturally understands and speaks the customer’s language by turning technical specs into an easy-to-understand conversation.Ultimately adapting to the customer’s conversation style to help better engage, educate and empower them in making purchase decisions in the moments that matter. With Zoovu's world-class semantic library you can easily interpret the context and intent behind your customers' every search.More than 3,500 brands and retailers use Zoovu to engage, educate and empower shoppers to find and buy the right product, including Amazon, P&G, Whirlpool and Microsoft. Zoovu operates worldwide in 500+ product categories, across all languages.
- Imverse — Imverse is an EPFL spin-off and a 3D graphics software company providing volumetric software components for tech companies creating products and services for the markets of installations, live broadcasting, and telepresence. Using their proprietary patent pending voxel engine, Imverse envisions to enable the 3D future of content & communicationthrough groundbreaking graphics technology.
- Syntheticus — Generate high-quality and compliant synthetic data at scale, that perfectly mimics real-world data tailored to your business and analytics needs.
Swisscom, Switzerland’s leading telecoms company and one of its leading IT companies, is headquartered in Ittigen, close to the capital city Berne. Swisscom’s international activities are concentrated mainly in Italy, where its subsidiary Fastweb is one of the biggest broadband providers. Around 21,500 employees achieve a revenues of CHF 2.89billion to the end of the 1st Quarter 2016. Swisscom is one of the most sustainable companies in Switzerland and Europe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Analytics
- Stage:Seed, Grant
- Geography: Switzerland, United States, Canada
Investor stats
- Total investments: 20
- Round size: Seed $555k–$3M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Ecoo2 — cablex and ECCO2 partner to deploy ECCO2 Building Intelligence
- SmartHelio — SmartHelio wants to be the doctor for solar plants: we remotely diagnose existing problems, predict faults and prescribe solutions in real time. Our team is made up of highly skilled engineers and scientists with deep domain knowledge of solar technology and data science. The company has developed a cost effective Edge Computing IoT device(HelioHealth, FitBit for Solar), world’s first in its category, that collects and processes data at the panel level using its proprietary physics-based algorithms. SmartHelio provide a dashboard or fully integrate into the existing customers’ IT platform. SmartHelio is deploying AI on Edge devices to reduce the cost of data collection, storage, and processing without compromising the quality of analytics services. This empower energy developers and managers to maintain their assets consistently at a high-performance level with minimum human intervention. SmartHelio is able to generate 5% extra energy and optimize 30% of O&M effort.
- Almer Technologies — Almer Technologies is a startup developing compact and lightweight augmented reality (AR) glasses to deliver effortless communication for frontline workers. Almer Technologies provides AR as a service, including hardware as well as software.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 155
- Round size: Seed $1.1M–$5.6M; Pre-Seed $850k–$1.3M; Series A $4.6M–$27M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- SureIn — small business insurance manager
- Colonia — Colonia is a logistics company that brings all global trucks and trailers into one shared fleet.
We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 188
- Round size: Seed $964k–$5M; Pre-Seed $500k–$3.2M; Series A $3.3M–$19M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
- Windup Minds — Windup Minds is a game studio focused on creating VR and MR virtual pet experiences. The company runs a gaming studio that aims to bring virtual pet games to market.
- Harbinger — Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans.
VC funding in Switzerland at a glance
Stats across 2.8k deals from 2k investors.
Access all 1976 VC funds in Switzerland startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the VC Funds in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1976 VC funds investing in Switzerland startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!